Page last updated: 2024-11-06

prednisolone and Fuchs' Endothelial Dystrophy

prednisolone has been researched along with Fuchs' Endothelial Dystrophy in 9 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Fuchs' Endothelial Dystrophy: Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.

Research Excerpts

ExcerptRelevanceReference
" Dosing was 4 times daily in months 1 to 3, thrice daily in month 4, twice daily in month 5, and once daily in months 6 to 12."2.79Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty. ( Bachmann, BO; Kruse, FE; Price, FW; Price, MO; Tourtas, T, 2014)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tourtas, T2
Schlomberg, J1
Wessel, JM1
Bachmann, BO2
Schlötzer-Schrehardt, U1
Kruse, FE2
Hos, D1
Heindl, LM1
Bucher, F1
Cursiefen, C1
Price, MO2
Price, FW2
Scanameo, A1
Feng, MT1
Bronner, A1
Erdurmus, M1
Cohen, EJ1
Yildiz, EH1
Hammersmith, KM1
Laibson, PR1
Varssano, D1
Rapuano, CJ1
Li, JY1
Terry, MA1
Goshe, J1
Shamie, N1
Davis-Boozer, D1
Hjortdal, J1
Pedersen, IB1
Bak-Nielsen, S1
Ivarsen, A1
Driebe, WT1
Park, JY1
Meisler, DM1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prospective Analysis of Loteprednol Etabonate Ophthalmic Suspension 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial Keratoplasty[NCT05136443]Phase 471 participants (Actual)Interventional2021-11-23Completed
Comparison Of Two Corticosteroid Dosing Regimens For Prevention Of Corneal Transplant Rejection Episodes After Descemet's Membrane Endothelial Keratoplasty[NCT01448213]Phase 2264 participants (Actual)Interventional2011-10-31Completed
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Prednisolone Acetate 1% Treating Pain, and inflamMation Following Corneal Transplant Surgery Compared to Topical Prednisolone Acetate 1%.[NCT04521140]Phase 436 participants (Actual)Interventional2020-10-16Completed
Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes[NCT00800111]2,593 participants (Actual)Interventional2008-02-29Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Eyes With Immunologic Graft Rejection Episodes

(NCT01448213)
Timeframe: Within 1 year

Interventioneyes (Number)
Fluorometholone 0.1% Solution2
Prednisolone Acetate 1% Solution0

Number of Eyes With Intraocular Pressure (IOP) Elevation

Absolute IOP greater than or equal to 24 mm Hg or a relative increase of 10 mm Hg over the baseline preoperative reading. (NCT01448213)
Timeframe: one day, two days, one week, one month, 3 months, 6 months and 12 months after DMEK

Interventioneyes (Number)
Fluorometholone 0.1% Solution9
Prednisolone Acetate 1% Solution32

Trials

1 trial available for prednisolone and Fuchs' Endothelial Dystrophy

ArticleYear
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:9

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2014
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:9

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2014
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:9

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2014
Randomized comparison of topical prednisolone acetate 1% versus fluorometholone 0.1% in the first year after descemet membrane endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:9

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2014

Other Studies

8 other studies available for prednisolone and Fuchs' Endothelial Dystrophy

ArticleYear
Graft adhesion in descemet membrane endothelial keratoplasty dependent on size of removal of host's descemet membrane.
    JAMA ophthalmology, 2014, Volume: 132, Issue:2

    Topics: Aged; Aged, 80 and over; Corneal Stroma; Descemet Membrane; Descemet Stripping Endothelial Keratopla

2014
Evidence of donor corneal endothelial cell migration from immune reactions occurring after descemet membrane endothelial keratoplasty.
    Cornea, 2014, Volume: 33, Issue:4

    Topics: Aged; Aged, 80 and over; Cell Count; Cell Movement; Descemet Stripping Endothelial Keratoplasty; End

2014
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
    Ophthalmology, 2016, Volume: 123, Issue:6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2016
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
    Ophthalmology, 2016, Volume: 123, Issue:6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2016
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
    Ophthalmology, 2016, Volume: 123, Issue:6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2016
Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids.
    Ophthalmology, 2016, Volume: 123, Issue:6

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cell Count; Corneal Endothelial Cell Loss;

2016
Descemet's stripping automated endothelial keratoplasty.
    Optometry and vision science : official publication of the American Academy of Optometry, 2008, Volume: 85, Issue:9

    Topics: Aged; Aged, 80 and over; Corneal Edema; Corneal Transplantation; Descemet Membrane; Endothelium, Cor

2008
Steroid-induced intraocular pressure elevation or glaucoma after penetrating keratoplasty in patients with keratoconus or Fuchs dystrophy.
    Cornea, 2009, Volume: 28, Issue:7

    Topics: Adolescent; Adult; Aged; Androstadienes; Female; Fluorometholone; Fuchs' Endothelial Dystrophy; Glau

2009
Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss.
    Ophthalmology, 2012, Volume: 119, Issue:1

    Topics: Aged; Cell Count; Corneal Endothelial Cell Loss; Descemet Stripping Endothelial Keratoplasty; Endoth

2012
Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy.
    Cornea, 2013, Volume: 32, Issue:5

    Topics: Aged; Aged, 80 and over; Chloramphenicol; Corneal Transplantation; Descemet Stripping Endothelial Ke

2013
Epithelial rejection rings.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1997, Volume: 115, Issue:7

    Topics: Administration, Topical; Aged; Aged, 80 and over; Cornea; Corneal Diseases; Corneal Transplantation;

1997